Trump Is Healthy, Doctor Says in Report That Shows He’s Obese
(Bloomberg) -- President Donald Trump is healthy, his doctor said in a report on his medical condition that showed he remains obese as measured by his body-mass index.
“Based on my history, examination and consultations, the data indicates the president remains healthy,” the White House physician, Sean Conley, said in a June 3 memo released to reporters.
He said that Trump completed his third physical as president in April. Conley said Trump weighs 244 pounds, one pound more than his last physical, and is 6 feet, three inches tall -- a combination that places him just over the threshold for obesity, according to the National Heart, Lung and Blood Institute.
The White House doctor reported no significant changes to the president's health. Trump's cholesterol level is down compared to the past two years; he takes 40 milligrams daily of the statin rosuvastatin, more widely known under the brand name Crestor, sold by AstraZeneca Plc. His blood pressure was up slightly while his resting heart rate was slightly down.
Conley confirmed that Trump took a two-week course of a malaria drug, hydroxychloroquine, after two White House staffers contracted Covid-19 in May. Trump took zinc and vitamin D supplements along with the drug, Conley said.
Trump Promoted Drug
Trump has promoted use of the drug to fight coronavirus infection though there is no strong clinical evidence it's effective. The drug can cause serious cardiovascular side effects, and the Food and Drug Administration has warned it should only be used in hospitalized Covid-19 patients.
“This was done in consultation with his appropriate care team members and close monitoring of the electrocardiogram (EKG) for changes in the QT interval,” Conley said. “The President completed the regimen safely and without side effects.”
Despite Trump's repeated attempts to tout the drug as an effective way to prevent contracting the virus, a new study of health-care workers, first responders and people living with Covid-19 patients showed it offered no protection.
The White House said Trump began the process of receiving his annual physical exam last November during an unannounced visit to a Washington-area hospital. That prompted speculation the president had a health problem, but then-press secretary Stephanie Grisham said it was for a routine examination and that it wasn't announced because of “schedule uncertainties.”
Conley said the results of his report released Wednesday “summarized data from visits conducted between November 2019 and April 2020” at Walter Reed National Military Medical Center in Bethesda, Maryland, and at the White House.
The doctor did not explain the why the president's physical took six months to complete.
©2020 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
